Author

R. L. Blosser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. J. Tam· 1 shared B. S. Slusher· 1 shared C. C. Cherry· 1 shared C. H. Patel· 1 shared D. R. Maestas· 1 shared E. Moore· 1 shared G. D. Rosson· 1 shared H. Y. Comeau· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. J. Tam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Biomaterials direct functional B cell response in a material specific manner

E. Moore, D. R. Maestas, C. C. Cherry, J. A. Garcia, H. Y. Comeau, L. Davenport Huyer, R. L. Blosser, G. D. Rosson, J. H. Elisseeff

This study shows that biomaterial composition influences B cell responses, with ECM materials inducing plasmablasts and antigen presentation, while synthetic PCL delays B cell migration and induces antigen-presenting phenotypes.

bioRxiv · Jan 12, 2021Bioengineering

Targeting glutamine metabolism enhances tumor specific immunity by inhibiting the generation of MDSCs and reprogramming tumor associated macrophages

M.-H. Oh, I.-H. Sun, L. Zhao, R. Leone, I.-M. Sun, W. Xu, S. L. Collins, A. J. Tam, R. L. Blosser, C. H. Patel, J. Englert, M. L. Arwood, J. Wen, Y. Chan-Li, P. Majer, , J. D. Powell

This study shows that targeting glutamine metabolism in tumors reduces MDSC generation, increases inflammatory macrophages, and enhances anti-tumor immunity, making checkpoint-resistant tumors responsive to immunotherapy.

bioRxiv · Jun 3, 2019 · PreprintImmunology